Snider Financial Group’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,255
Closed -$229K 64
2023
Q1
$229K Buy
+10,255
New +$248K 0.12% 46
2022
Q4
Sell
-15,754
Closed -$293K 56
2022
Q3
$293K Sell
15,754
-1,882
-11% -$42.3K 0.16% 47
2022
Q2
$351K Buy
17,636
+4,363
+33% +$88.1K 0.19% 46
2022
Q1
$366K Buy
13,273
+3,768
+40% +$108K 0.17% 46
2021
Q4
$404K Buy
9,505
+413
+5% +$18.2K 0.17% 49
2021
Q3
$435K Sell
9,092
-67
-0.7% -$2.92K 0.19% 48
2021
Q2
$349K Buy
+9,159
New +$392K 0.16% 51

Other funds holding VCYT

Snider Financial Group's VCYT Position: Q2 2023 in Review

Snider Financial Group sold out of Veracyte (VCYT) in Q2 2023, closing a stake of 10,255 shares — an estimated $229K sold.

Snider Financial Group first reported a position in VCYT in Q2 2021 and held it in 7 quarters. The position peaked at $435K in Q3 2021. 232 funds tracked by Wall St. Rank hold VCYT as of Q2 2023.

  • Snider Financial Group reported no remaining Veracyte position as of Q2 2023 after selling out during the quarter.
  • Snider Financial Group sold 10,255 Veracyte shares in Q2 2023, an estimated $229K.
  • Snider Financial Group first reported a position in Veracyte in Q2 2021 and held it in 7 quarters.
  • Snider Financial Group's Veracyte position peaked at $435K in Q3 2021.
  • 232 funds tracked by Wall St. Rank held Veracyte as of Q2 2023.

Based on Snider Financial Group's 13F filing for Q2 2023, filed 19 Jul 2023.